The Trump administration released the next 15 drugs subject to Medicare price negotiation, including for the first time ...

The South Carolina measles outbreak has surpassed the recorded case count in Texas' 2025 outbreak, as health officials have ...

HCA Healthcare put out a 2026 forecast that delighted investors, despite challenges from Medicaid and the ACA.

In his final moments, Alex Pretti did what nurses are educated to do, a nurse writes. He noticed, cared, and responded to an ...

U.K. health officials are facing pressure to rethink how they expand the list of diseases that all newborns are screened for ...

Good morning. A new startup focused on GLP-1 drugs launched today, but unlike the dozens of other GLP-1 companies, this one isn’t studying weight loss. Roche plans to launch Phase 3 studies of its ...

UnitedHealth took a $1.6 billion charge, net of taxes, in the fourth quarter of 2025 that reflected final costs from the 2024 ...

When trial participants aren't representative, the evidence for universally adopted cancer treatment guidelines is incomplete ...

Y ou’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life ...

Roche plans to launch Phase 3 studies of its leading obesity candidate this quarter after reporting Tuesday that the drug led ...

The qualified medical experts, the pseudoscientific entertainers, and the MAHA mobilizers leading online health content today.

Roche plans to launch Phase 3 studies of its leading obesity candidate this quarter after the drug led to significant weight loss in a mid-stage trial ...